Co announces that the FDA has granted final approval for the Company's Abbreviated New Drug Application for Rabeprazole Sodium Delayed-Release Tablets, 20 mg. TEVA's Rabeprazole Sodium Delayed-Release ...
Omeprazole is a commonly prescribed medication in the UK, but there are some risks associated with long-term use, including ...
Other medical conditions addressed by PPIs include indigestion, healing of stomach ulcers, gastro-oesophageal reflux disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback